UK Markets open in 3 hrs 59 mins
NIKKEI 225
26,734.54 +564.24 (+2.16%) HANG SENG
23,566.37 -240.63 (-1.01%) CRUDE OIL
87.09 +0.48 (+0.55%) GOLD FUTURES
1,797.70 +4.60 (+0.26%) DOW
34,160.78 -7.31 (-0.02%) BTC-GBP
27,862.91 +1,062.52 (+3.96%)
Cara Therapeutics, Inc. (CARA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 11.39 |
| Open | 11.46 |
| Bid | 10.92 x 900 |
| Ask | 11.00 x 800 |
| Day's range | 10.93 - 11.64 |
| 52-week range | 10.83 - 29.65 |
| Volume | |
| Avg. volume | 579,949 |
| Market cap | 587.511M |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | 22.94 |
| EPS (TTM) | 0.48 |
| Earnings date | 23 Feb 2022 - 28 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.25 |
- Zacks
Horizon (HZNP) Begins Enrollment in Rare Lung Disease Study
Horizon (HZNP) enrolls the first patient in a phase IIb study evaluating HZN-825 for the treatment of idiopathic pulmonary fibrosis.
- Simply Wall St.
Do Institutions Own Cara Therapeutics, Inc. (NASDAQ:CARA) Shares?
If you want to know who really controls Cara Therapeutics, Inc. ( NASDAQ:CARA ), then you'll have to look at the makeup...
- Motley Fool
Cara Therapeutics, inc (CARA) Q3 2021 Earnings Call Transcript
Please be advised that this call is being recorded at Cara's request. This is Will Gramig with Stern Investor Relations, and welcome to Cara Therapeutics' third quarter 2021 financial results and update conference call. Before we begin, let me remind you that statements made on today's call regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
© 2022 Yahoo. All rights reserved.
